Skip to main content
Clinical Trials/NCT00862576
NCT00862576CompletedNot Applicable

A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome

University of California, San Francisco1 site in 1 country55 target enrollmentStarted: June 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
55
Locations
1
Primary Endpoint
Sleep quality and quantity

Study Overview

Brief Summary

This is a case control study of the association between burning mouth syndrome and sleep dysfunction. Cases will comprise of patients diagnosed with burning mouth syndrome at the UCSF oral medicine clinic. Controls will include patients with leukoplakia, pigmented lesions, traumatic lesions, benign tumors, mucoceles, and pemphigoid matched on age (5 years) and gender to the cases. New patients as well as those presenting for follow-up visits will be eligible.

Each case and control subject will be administered the following 4 questionnaires by interview: (1) enrollment questionnaire (2) Sleep scale from the medical outcomes study (MOS), (3) current sleep status scale and (4) a numerical rating scale for measurement of oral symptoms.

Cases (BMS patients) will be followed in the clinic or by telephone contact once per month for the following 6 months and questionnaires 1 (question 6 only), 2, 3 and 4 will be administered by interview.

Study Design

Study Type
Observational
Observational Model
Case Control

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Cases will comprise of patients diagnosed with burning mouth syndrome at the UCSF oral medicine clinic.
  • Controls will include patients with leukoplakia, pigmented lesions, traumatic lesions, aphthous ulcers, reticular oral lichen planus, benign tumors, mucoceles, and pemphigoid matched on age (5 years) and gender to the cases.
  • New patients as well as those presenting for follow-up visits will be eligible.

Exclusion Criteria

  • Age below 18 years
  • Pregnancy
  • Systemic corticosteroid therapy within the previous 2 weeks.

Outcomes

Primary Outcomes

Sleep quality and quantity

Secondary Outcomes

No secondary outcomes reported

Investigators

Study Sites (1)

Loading locations...

Similar Trials